Why is Kailera Therapeutics, Inc. stock up today?
September 23, 2026
Kailera Therapeutics, Inc.
KLRA · NMS · USD
vs. prev. close $12.79
Last updated Sep 23, 2026 20:00
Intraday Chart — 5-min intervals
KLRA · less than a minute ago
Kailera Therapeutics, Inc. gains 2.66%: news, volume, and market context
The stock is at $13.13, a 2.66% move up versus the prior close of $12.79. Market context matters here: S&P 500: -0.8%, Nasdaq: -1.1%, Dow Jones: -0.7%, Shanghai: -0.3%, Hang Seng: -0.8%, leaving the overall tape under pressure.
The news backdrop is active, led by "Kailera Therapeutics to Participate in September Investor Conferences" and "Jim Cramer Calls Kailera Therapeutics (KLRA) “The Most Speculative Stock On Earth”"; the headline mix is leaning negative.
Use this as a starting point for research, not as a trading recommendation.
Key Factors
Auto-generated analysis · Not financial advice

Kailera Therapeutics to Participate in September Investor Conferences
GlobeNewswire·7 days agoneutral
Jim Cramer Calls Kailera Therapeutics (KLRA) “The Most Speculative Stock On Earth”
Insider Monkey·9 days agoneutral
Kailera Therapeutics: The Record-Breaking Obesity IPO Big Pharma Cannot Ignore
24/7 Wall St.·about 1 month agoneutral
Kailera Therapeutics (KLRA) Reports Wider Losses And Names New CTO, Is The Low P B Justified?
Simply Wall St.·about 1 month agonegative
2 GLP-1 Stocks That Could Double Your Money by 2031
Motley Fool·about 1 month agoneutral
Kailera Reports Second Quarter 2026 Financial Results and Provides Business Updates
GlobeNewswire·about 1 month agoneutralKailera Therapeutics Appoints Nur Nicholson as Chief Technology Officer
GlobeNewswire·about 1 month agoneutral2 Beaten-Down GLP-1 Stocks to Buy on the Dip
Motley Fool·2 months agoneutral
S&P 500
-0.75%
Nasdaq
-1.13%
Dow Jones
-0.68%
Shanghai
-0.34%
Hang Seng
-0.83%
Nikkei 225
+1.38%
FTSE 100
-0.03%
Nifty 50
+0.14%
DAX
-0.66%
OMX Stockholm
-0.57%
Search another stock